These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 32654913

  • 1. Incidence and outcome of post-transplant lymphoproliferative disorders in lung transplant patients: Analysis of ISHLT Registry.
    Zaffiri L, Long A, Neely ML, Cherikh WS, Chambers DC, Snyder LD.
    J Heart Lung Transplant; 2020 Oct; 39(10):1089-1099. PubMed ID: 32654913
    [Abstract] [Full Text] [Related]

  • 2. Increased risk of PTLD in lung transplant recipients with cystic fibrosis.
    Lowery EM, Adams W, Grim SA, Clark NM, Edwards L, Layden JE.
    J Cyst Fibros; 2017 Nov; 16(6):727-734. PubMed ID: 28456611
    [Abstract] [Full Text] [Related]

  • 3. Posttransplant Lymphoproliferative Disorders in Epstein-Barr Virus Donor Positive/Recipient Negative Lung Transplant Recipients.
    Courtwright AM, Burkett P, Divo M, Keller S, Rosas IO, Trindade A, Mody GN, Singh SK, El-Chemaly S, Camp PC, Goldberg HJ, Mallidi HR.
    Ann Thorac Surg; 2018 Feb; 105(2):441-447. PubMed ID: 29223419
    [Abstract] [Full Text] [Related]

  • 4. Posttransplant Lymphoproliferative Disorders in Irish Renal Transplant Recipients: Insights From a National Observational Study.
    OʼRegan JA, Prendeville S, McCaughan JA, Traynor C, OʼBrien FJ, Ward FL, OʼDonovan D, Kennedy C, Berzan E, Kinsella S, Williams Y, OʼKelly P, Deady S, Comber H, Leader M, Conlon PJ.
    Transplantation; 2017 Mar; 101(3):657-663. PubMed ID: 27214265
    [Abstract] [Full Text] [Related]

  • 5. Lymphoproliferative disorders after adult kidney transplant: epidemiology and comparison of registry report with claims-based diagnoses.
    Kasiske BL, Kukla A, Thomas D, Wood Ives J, Snyder JJ, Qiu Y, Peng Y, Dharnidharka VR, Israni AK.
    Am J Kidney Dis; 2011 Dec; 58(6):971-80. PubMed ID: 21930332
    [Abstract] [Full Text] [Related]

  • 6. Incidence and predictors of post-transplant lymphoproliferative disease after kidney transplantation during adulthood and childhood: a registry study.
    Francis A, Johnson DW, Teixeira-Pinto A, Craig JC, Wong G.
    Nephrol Dial Transplant; 2018 May 01; 33(5):881-889. PubMed ID: 29342279
    [Abstract] [Full Text] [Related]

  • 7. Idiopathic pulmonary fibrosis lung transplant recipients are at increased risk for EBV-associated posttransplant lymphoproliferative disorder and worse survival.
    Iasella CJ, Winters SA, Kois A, Cho J, Hannan SJ, Koshy R, Moore CA, Ensor CR, Lendermon EA, Morrell MR, Pilewski JM, Sanchez PG, Kass DJ, Alder JK, Nouraie SM, McDyer JF.
    Am J Transplant; 2020 May 01; 20(5):1439-1446. PubMed ID: 31874120
    [Abstract] [Full Text] [Related]

  • 8. Transplantation for congenital heart disease is associated with an increased risk of Epstein-Barr virus-related post-transplant lymphoproliferative disorder in children.
    Offor UT, Bacon CM, Roberts J, Powell J, Brodlie M, Wood K, Windebank KP, Flett J, Hewitt T, Rand V, Hasan A, Parry G, Gennery AR, Reinhardt Z, Bomken S.
    J Heart Lung Transplant; 2021 Jan 01; 40(1):24-32. PubMed ID: 33339556
    [Abstract] [Full Text] [Related]

  • 9. Posttransplantation lymphoproliferative disorder in lung transplant recipients: a 15-year single institution experience.
    Muchtar E, Kramer MR, Vidal L, Ram R, Gurion R, Rosenblat Y, Bakal I, Shpilberg O.
    Transplantation; 2013 Oct 15; 96(7):657-63. PubMed ID: 23823652
    [Abstract] [Full Text] [Related]

  • 10. Post-transplantation lymphoproliferative disorder in the Epstein-Barr virus-naïve lung transplant recipient.
    Aris RM, Maia DM, Neuringer IP, Gott K, Kiley S, Gertis K, Handy J.
    Am J Respir Crit Care Med; 1996 Dec 15; 154(6 Pt 1):1712-7. PubMed ID: 8970360
    [Abstract] [Full Text] [Related]

  • 11. Impact of Epstein-Barr virus donor and recipient serostatus on the incidence of post-transplant lymphoproliferative disorder in kidney transplant recipients.
    Sampaio MS, Cho YW, Shah T, Bunnapradist S, Hutchinson IV.
    Nephrol Dial Transplant; 2012 Jul 15; 27(7):2971-9. PubMed ID: 22273720
    [Abstract] [Full Text] [Related]

  • 12. Epstein-Barr virus primary mismatching and HLA matching: key risk factors for post lung transplant lymphoproliferative disease.
    Wong JY, Tait B, Levvey B, Griffiths A, Esmore DS, Snell GI, Williams TJ, Kotsimbos TC.
    Transplantation; 2004 Jul 27; 78(2):205-10. PubMed ID: 15280679
    [Abstract] [Full Text] [Related]

  • 13. Post-transplant lymphoproliferative disorders occurring after renal transplantation in adults: report of 230 cases from the French Registry.
    Caillard S, Lelong C, Pessione F, Moulin B, French PTLD Working Group.
    Am J Transplant; 2006 Nov 27; 6(11):2735-42. PubMed ID: 17049061
    [Abstract] [Full Text] [Related]

  • 14. Posttransplant lymphoproliferative disorder: incidence, presentation, and response to treatment in lung transplant recipients.
    Reams BD, McAdams HP, Howell DN, Steele MP, Davis RD, Palmer SM.
    Chest; 2003 Oct 27; 124(4):1242-9. PubMed ID: 14555552
    [Abstract] [Full Text] [Related]

  • 15. Systematic review and meta-analysis of post-transplant lymphoproliferative disorder in lung transplant recipients.
    Cheng J, Moore CA, Iasella CJ, Glanville AR, Morrell MR, Smith RB, McDyer JF, Ensor CR.
    Clin Transplant; 2018 May 27; 32(5):e13235. PubMed ID: 29517815
    [Abstract] [Full Text] [Related]

  • 16. Post-transplantation lymphoproliferative disorder in heart and kidney transplant patients: a single-center experience.
    Wasson S, Zafar MN, Best J, Reddy HK.
    J Cardiovasc Pharmacol Ther; 2006 Mar 27; 11(1):77-83. PubMed ID: 16703222
    [Abstract] [Full Text] [Related]

  • 17. Post-transplant lymphoproliferative disease in heart and lung transplantation: Defining risk and prognostic factors.
    Kumarasinghe G, Lavee O, Parker A, Nivison-Smith I, Milliken S, Dodds A, Joseph J, Fay K, Ma DD, Malouf M, Plit M, Havryk A, Keogh AM, Hayward CS, Kotlyar E, Jabbour A, Glanville AR, Macdonald PS, Moore JJ.
    J Heart Lung Transplant; 2015 Nov 27; 34(11):1406-14. PubMed ID: 26279197
    [Abstract] [Full Text] [Related]

  • 18. Low 5-year cumulative incidence of post-transplant lymphoproliferative disorders after solid organ transplantation in Switzerland.
    Steiner R, Kridel R, Giostra E, McKee T, Achermann R, Mueller N, Manuel O, Dickenmann M, Schuurmans MM, de Leval L, Fehr T, Tinguely M, Binet I, Cogliatti S, Haralamvieva E, Koller M, The Swiss Transplant Cohort Study Stcs, Dietrich PY.
    Swiss Med Wkly; 2018 Nov 27; 148():w14596. PubMed ID: 29518251
    [Abstract] [Full Text] [Related]

  • 19. Incidence, Risk Factors, Clinical Management, and Outcomes of Posttransplant Lymphoproliferative Disorder in Kidney Transplant Recipients.
    Liu M, Husain S, Famure O, Li Y, Kim SJ.
    Prog Transplant; 2019 Jun 27; 29(2):185-193. PubMed ID: 30845885
    [Abstract] [Full Text] [Related]

  • 20. Early onset post-transplant lymphoproliferative disease is associated with allograft localization.
    Bakker NA, van Imhoff GW, Verschuuren EA, van Son WJ, Homan van der Heide JJ, Veeger NJ, Kluin PM, Kluin-Nelemans HC.
    Clin Transplant; 2005 Jun 27; 19(3):327-34. PubMed ID: 15877793
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.